PressNovember 9, 2022 Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
PressNovember 7, 2022 Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET
PressNovember 7, 2022 Revitalist CEO Awarded Professional Service Practitioner of the Year by Microdose
PressNovember 4, 2022 Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression
PressNovember 4, 2022 Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference – November 15-17, 2022
PressNovember 4, 2022 COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
PressNovember 3, 2022 Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events
PressNovember 3, 2022 MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update
PressNovember 3, 2022 First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder
PressNovember 3, 2022 COMPASS Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine
PressNovember 3, 2022 Silo Wellness Breaking News: Jackson County Oregon’s Proposed TPM Restrictions Put Rural Psilocybin Retreat Therapy Centers at Risk
PressNovember 2, 2022 Revitalist Releases Supplement Line to Enhance the Results of Psychedelic Medicines
PressNovember 2, 2022 Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders
PressNovember 2, 2022 atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
PressNovember 2, 2022 Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders
PressNovember 1, 2022 Revitalist Increases Patient Access Making Care More Affordable by Financing the Cost With M-Lend Financial
PressNovember 1, 2022 Cybin Announces Scientific Presentation at the 5th Annual Neuropsychiatric & Psychedelics Drug Development Summit
PressNovember 1, 2022 PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University to Develop and Commercialize Ketamine for Rett Syndrome
PressNovember 1, 2022 Irwin Naturals Looks to Add to Florida Foothold, Expanding Chain of Healthcare Clinics
